Mesenchymal chondrosarcoma is aggressive variant of chondrosarcoma, which tend to occur in younger people. Figure 4 clear cell chondrosarcoma lining wall of hemorrhagic abc cystlike space 400. Often large painful tumors of long bones or ribs that grow rapidly during adolescence and reach 8 cm or larger. They are frequently seen in the 4th and 5th decades with a slight male predominance 1. The patient remained free until she complained of right sciatic pain 5 months later.
Mesenchymal chondrosarcoma mcs is a rare histological variant of chondrosarcoma, with aggressive behaviour. Pathology they tend to be of higher grade than runofthemill conventional intramedullary chondrosarcomas, with the majority being of t. Childhood tumors usually involve extremities and are often chondroblastic osteosarcomas. Low grade chondrosarcoma of bone with unusual metastatic. Mesenchymal chondrosarcomamcs is a rare highgrade variant of chondrosarcoma. Chondrosarcoma is a malignant cancer that results in abnormal bone and cartilage growth. Extraskeletal mesenchymal chondrosarcoma emcs is a rare and. Conventional chondrosarcoma also known as central chondrosarcoma is the most common subtype of chondrosarcoma and may be low, intermediate or.
Chondrosarcoma is a malignant tumor composed of cartilageproducing cells. Localized chondrosarcoma has not spread out of the bone where the cancer started. Surgery can help in some cases, but otherwise they all seem to say the same thing vague recommendations to try chemotherapy or radiation. Mesenchymal chondrosarcoma immunohistostaining photomicrographs. Prognosis for the highgrade chondrosarcoma and the dedifferentiated chondrosarcoma is poor with lower survival rates. Chondrosarcoma is a member of a category of tumors of bone and soft tissue known as sarcomas. In most other domestic species, chondrosarcoma is a relatively. Recently, a randomized phase 2 study in patients with translocationrelated sarcomas unresponsive or intolerable to standard chemotherapy was conducted, which showed clinical benefit of trabectedin compared with best supportive care bsc. Patients with mesenchymal chondrosarcoma who received. Mesenchymal chondrosarcoma was first described in the medical literature in 1959.
This cancer can also occur in animals such as cats and dogs. Chondrosarcoma article about chondrosarcoma by the free. The condition is classified into several categories depending on the appearance of the tumor under the microscope. Conventional chondrosarcoma is a form of bone cancer that arises from cartilage cells. Mesenchymal chondrosarcoma nord national organization.
Middleaged to elderly individuals are most prone to. A rare case of extraskeletal mesenchymal chondrosarcoma with. There are several staging systems for chondrosarcoma, but no single staging system applies to all types of this cancer. This tumor is most common in children and young adults aged 1030, but can affect individuals of any age including young children and older adults.
Aggressive surgical resection of mesenchymal chondrosarcoma with. It is the second most common primary malignancy of bone, and one of the most difficult bone tumors to diagnose and treat. Unlike other primary bone cancers that mainly affect children. Once chondrosarcoma is found, biopsy tests will be done to find out if the cancer cells have spread to other parts of the body. Know the grades, types, causes, symptoms, treatment and prognosis of chondrosarcoma. Mesenchymal chondrosarcomas are rare tumors that account for 210% of primary chondrosarcomas.
The purpose of this longterm retrospective study was to examine a group of patients with primary central chondrosarcoma of bone who presented with localized disease and were treated with a uniform surgical protocol at our institution, in order to determine the factors that influence overall and eventfree survival. Mesenchymal chondrosarcoma mcs is a distinct, very rare sarcoma with little evidence. Unlike other primary bone cancers that mainly affect children and adolescents, chondrosarcoma can present at any age. Chondrosarcoma grades iiii, including primary and secondary variants and periosteal chondrosarcoma. Chondrosarcoma is a member of a category of tumours of bone and soft tissue known as sarcomas. The patient received radical surgery and has been disease free for 40 months. People who have chondrosarcoma have a single tumor growth which can vary in size and location when first discovered. It develops from normal cartilage which goes through malignant change or can form within a preexisting benign tumor. Mesenchymal chondrosarcoma mcs is a rare highgrade of variant of chondrosarcoma first described in 1959. Mesenchymal chondrosarcoma of bone and soft tissue plos. Mcs differs from typical chondrosarcomas in the following respects. It is a rare cancer that accounts for about 20% of bone tumors and is diagnosed in approximately 600 patients each year in the united states. Mesenchymal chondrosarcoma is a type of chondrosarcoma, which itself is a type of bone cancer that has its origins in cartilage cells.
Extraskeletal myxoid chondrosarcoma emc is an infrequent, lowgrade tumor of the soft tissues, forming around bones. Chondrosarcoma chs is a malignant cartilageforming tumor and usually occurs within the medullary canal of long bones and pelvic bones. The rest of the time, the cancer actually develops in other areas of the. Elmofty, in diagnostic surgical pathology of the head and neck second edition, 2009.
Sirisha devi, dhananjay ghosh departments of radiation oncology and medicine 1, batra hospital and medical research centre, new delhi 162, india. Chondrosarcomas article about chondrosarcomas by the. Sixtyfive of 95 patients are alive and 45 progressionfree 5 local recurrence, 34 distant metastases, 11 combined. The disease recently was reported to have a median eventfree survival of 57 months 25. Chondrosarcoma hxbenefit recent health articles and news. Because, unfortunately, when it comes to fighting chondrosarcoma in dogs, most vets even the cancer specialists arent very helpful. Negative surgical margins could significantly bring. Pdf on dec 5, 2016, amin saburi and others published intracranial mesenchymal chondrosarcoma. The term secondary chondrosarcoma refers to those that develop by malignant transformation of cartilage in an osteochondroma. Mesenchymal chondrosarcoma in children and young adults. Because chondrosarcoma is highly resistant to chemotherapy and radiotherapy, surgical treatment is the only option for curative treatment. The identification of prognostic factors and survival. Subtypes vary substantially chondrosarcoma nos and myxoid chondrosarcoma have a five year survival of 70%, but mesenchymal chondrosarcoma only 50%, and dedifferentiated chondrosarcoma an abysmal 0%. Intracranial mesenchymal chondrosarcoma is very rare, only 14 cases being reported in europe and in the united.
The prognosis of central chondrosarcoma is generally good for the histologically lowgrade tumors. Emcs is marked by 40% incidence of metastases in spite of its indolent behaviour. B e careful not to blindly follow your veterinarians conventional dog cancer recommendations. The doctor needs to know the stage of the cancer in order to plan treatment. Poor prognostic factors in conventional chondrosarcoma for overall survival are highgrade tumors and axialpelvic tumor location. Chondrosarcoma is a cancer composed of cells derived from transformed cells that produce cartilage. Mesenchymal chondrosarcoma an overview sciencedirect. Chondrosarcoma is a locally aggressive to malignant cartilaginous matrix producing neoplasm. Their typical histological appearance includes a biphasic pattern with areas of round, primitive mesenchymal cells and interspersed islands of well differentiated hyaline cartilage. Extraskeletal mesenchymal chondrosarcoma carry mixed features of ewing sarcoma and chondrosarcoma, while extraskeletal myxoid. Mesenchymal chondrosarcoma is a rare malignant tumor arising from bone or soft tissues. Mesenchymal chondrosarcoma is an aggressive, uncommon histologic entity arising in bone and soft tissues. Extraskeletal chondrosarcoma radiology reference article.
Mostly mc arises from the craniofacial bones, the ribs, the ilium, the. It only accounts for 1% to 10% of all chondrosarcomas24. One third to one half of mcs are extraosseous in origin. Chondrosarcoma is mainly seen in adults in the third till sixth decade of life, with equal distribution among genders. About 30% of skeletal system cancers are chondrosarcoma. Canine chondrosarcoma causes, treatment and progonsis. This is why roughly 60% of cases of mesenchymal chondrosarcoma affect the patients bones. All structured data from the file and property namespaces is available under the creative commons cc0 license. The histopathologic margins of the excised lesion were free of the tumor.
Figure 6 metastatic mesenchymal chondrosarcoma to adrenal gland. Chondrosarcoma musculoskeletal medicine for medical. You were so generous to give up your time on a weekend to operate on my femur. Results of subanalysis of a phase 2 study on trabectedin. Based on the morphologic feature alone, a correct diangosis of chs may be difficult, therefore, correlation of radiological and clinicopathological features is mandatory in the diagnosis of chs. Chondrosarcoma is reported most frequently in the dog, where it accounts for 10% of primary tumors of bones and is second only to osteosarcoma in incidence. Usually a good prognosis 75% five year survival in one large data set. About 30% of skeletal system cancers are chondrosarcomas. Histologically, mcs has a typical biphasic pattern consisting of both small cells and islands of atypical cartilage. Extraskeletal chondrosarcoma is a rare type of chondrosarcomadoes, which forms in the soft tissues, rather than bone cartilage. The mesenchymal chondrosarcoma mc is a rare malignant tumour and accounts for less than 3% of primary chondrosarcomas. Chondrosarcoma biopsy bone free 30day trial scribd. Clinical benefit of antiangiogenic therapy in advanced and.
Low grade chondrosarcoma 10 year survival rate 90% high grade chondrosarcoma 10 year survival rate 2040% recurrence generally have higher grade than primary malignancy bcoz slow growing tumour and recurrence or mets cant be detected years after primary procedure long term follow up with regular imaging of operative site and chest. Trabectedin is reported to be particularly effective against translocationrelated sarcoma. Mesenchymal chondrosarcoma mc accounts for 3% to 5% of all chondrosarcomas. Pdf diagnosis and prognosis of chondrosarcoma of bone. Extraskeletal chondrosarcomas make up only 2% of softtissue sarcomas and only 1% of all chondrosarcomas. Chondrosarcoma is the second most common primary cancer of the bone. Find out about the symptoms, causes, and treatment of chondrosarcoma, a type of bone cancer most common in your pelvis, thighbone, or upper arm. Do you know the risk factors, diagnostic strategies, and treatment approaches for these cancers. Chondrosarcoma is a type of sarcoma that affects the bones and joints. Treatment without surgery is associated with poorer overall survival and eventfree survival. Due to the unique nature of this disease, management strategies are not well established. Conventional intramedullary chondrosarcoma dr rohit sharma and assoc prof frank gaillard et al. They usually arise in the thoracic bones, pelvic and long bones. Mesenchymal chondrosarcoma is an extremely rare, often aggressive form of cancer.
The metastasis rate in the primary chondrosarcoma 42% was higher than that in the secondary chondrosarcomas 0% p0. People who have chondrosarcoma have a tumor growth starting from the medullary canal of a long and flat bone. Four patients developed pulmonary metastasis only, 5 developed both pulmonary metastases and metastases of the other sites. Wittig, i am writing at a loss to find adequate words to thank you for all that you have done for me.
The disease usually starts in the bones of the arms. Chondrosarcoma is described as either localized or metastatic. Lifraumeni syndrome lfs is a rare cancer predisposition syndrome with a wide tumour spectrum, associated with tp53 germline mutations. Chondrosarcoma a malignant tumor of cartilage tissue, sometimes accompanied by mucous degeneration. Conventional intramedullary chondrosarcoma radiology. Associated with preexisting enchondroma, but not with chondroblastoma, osteochondroma, fibrous dysplasia or pagets disease. Chondrosarcoma can occur at any age but is more common in people older than 40 years.
The median survival time for dogs with skeletal chondrosarcoma varies between 201 and 1080 days, with treatment, depending upon the location and type of the tumor. A 19 year old female patient presented with chondrosarcoma in left mandibular region near angle of mouth. Cartilage is the specialized tissue that serves as a buffer or cushion at joints. Mesenchymal chondrosarcoma of bone and soft tissue. Treatment without surgery is associated with poorer overall survival and event free survival. The term chondrosarcoma is used to define an heterogeneous group of lesions with diverse features and clinical behavior. Grade and stage are independent predictors of survival. Fewer than 40 cases of mesenchymal chondrosarcoma in the maxilla have been reported in english literature.
Files are available under licenses specified on their description page. They are two to three times more common in bone than in soft tissue and are mostly found in the. They develop mostly on the inferior metaphysis of the femur, the pelvic bones, and the ribs. Chondrosarcoma is a rare and malignant cancer which affects the joints and bones.
1355 1187 41 578 114 524 958 529 657 588 432 700 63 1060 692 1199 367 1320 544 1555 1108 389 23 1520 1659 319 931 913 617 1543 1478 933 510 182 1494 824 587 644 764 403 843